KMO and Salmonella Infections: We had previously shown that neither treatment with the Kmo inhibitor Ro61–8048, exogenous application of 3-HK, or the KAR antagonist NS 3763 had any impact on S. Typhimurium infection in an array of cultured cell lines and primary cells typically used to model Salmonella infection, including macrophages and epithelial cells [1].